Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
06:21pm, Wednesday, 03'rd Jun 2026
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Repligen Has A Cleaner Recovery Angle, But With High Valuation
09:15am, Sunday, 31'st May 2026
Repligen Has A Cleaner Recovery Angle, But With High Valuation
Repligen Corp (RGEN) Stock Up 8.4% and Still Undervalued -- GF Score: 79/100
06:47pm, Thursday, 28'th May 2026
On May 28, 2026, Repligen Corp (RGEN) shares rose 8.4% today, bringing the current price to $122.73. The stock has experienced volatility over the past year, tr
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
07:30am, Friday, 22'nd May 2026
WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in
Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report
07:30am, Wednesday, 20'th May 2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
04:11pm, Tuesday, 12'th May 2026
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
07:30am, Thursday, 07'th May 2026
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
12:50pm, Wednesday, 06'th May 2026
RGEN tops Q1 earnings and revenue estimates, sending shares higher as strong chromatography and analytics business aid growth. The company raises its 2026 EPS view.
Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript
02:41pm, Tuesday, 05'th May 2026
Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates
10:15am, Tuesday, 05'th May 2026
Repligen (RGEN) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.39 per share a year ago.
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
07:00am, Tuesday, 05'th May 2026
WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its fi
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:01am, Thursday, 30'th Apr 2026
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alger Mid Cap Growth Fund Q1 2026 Portfolio Review
04:10am, Wednesday, 29'th Apr 2026
Class A shares of the Alger Mid Cap Growth Fund underperformed the Russell Midcap Growth Index during the first quarter of 2026. FTAI Aviation Ltd., Vertiv Holdings Co. and Comfort Systems USA, Inc.,
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for
11:06am, Tuesday, 28'th Apr 2026
Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
03:29pm, Monday, 27'th Apr 2026
The Conestoga SMid Cap Composite returned -10.24% net-of-fees in the first quarter, lagging the Russell 2500 Growth Index's return of -3.52%. RBC's performance was driven by continued strength in aero
